Skip to main content
. Author manuscript; available in PMC: 2018 Jan 22.
Published in final edited form as: J Alzheimers Dis. 2017;58(2):401–411. doi: 10.3233/JAD-160965

Figure 2. Mean (SD) Plasma Concentration of ELND005 (μg/mL) versus Time.

Figure 2

Plasma levels were calculated based on peripheral venous blood samples that were collected from indwelling catheters or by direct venipuncture into collection tubes. Baseline (Visit 2) and Day 28 (EOS) blood samples for ELND005 plasma levels were collected before dosing (time 0), and at 1.5 (±0.5), 3 (±0.5), and 4.5 (±0.5) hours after dosing. In addition, patients were encouraged to provide blood samples at 6 (±1) and 8 (±1) hours after dosing. At Day 14, one blood sample was collected (either before or after the first dose of study drug on Day 14).